Analysis of acquired resistance genes in stenotrophomonas maltophilia

Korean Journal of Laboratory Medicine

Volumn 30, Issue 3, 2010, Pages 295-300

  Song, Jeong Hoon ^a   Sung, Ji Youn ^a   Kwon, Kye Chul ^a   Park, Jong Woo ^a   Cho, Hye Hyun ^a   Shin, So Yeon ^a   Ko, Young Hyun ^a   Kim, Ji Myung ^b   Shin, Kyeong Seob ^c   Koo, Sun Hoe ^a  

^a Chungnam National University   (South Korea)

^b Eulji University   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

Class 1 integron; Stenotrophomonas maltophilia; Sul1 gene; Trimethoprim sulfamethoxazole

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CARRIER PROTEIN; COTRIMOXAZOLE; SUL2 PROTEIN, BACTERIA;

ARTICLE; DISK DIFFUSION; DRUG EFFECT; GENETICS; HUMAN; INTEGRON; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; DISK DIFFUSION ANTIMICROBIAL TESTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTEGRONS; POLYMERASE CHAIN REACTION; STENOTROPHOMONAS MALTOPHILIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77955497109     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2010.30.3.295     Document Type: Article

References (20)

1. Chang LL, Lin HH, Chang CY, Lu PL. Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 2007; 59: 1038-9.
2. Valdezate S, Vindel A, Loza E, Baquero F, Canton R. Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother 2001; 45: 15814.
3. Ahn GY, Yu FN, Jang SJ, Kim DM, Park G, Moon DS, et al. Pseudooutbreak of Stenotrophomonas maltophilia due to contamination of bronchoscope. Korean J Lab Med 2007; 27: 205-9.
4. Harlowe HD. Acute mastoiditis following pseudomonas maltophilia infection: case report. Laryngoscope 1972; 82: 882-3.
5. Sutter VL. Identification of Pseudomonas species isolated from hospital environment and human sourcés. Appl Microbiol 1968; 16: 1532-8.
6. Ben-Tovim T, Eylan E, Romano A, Stein R. Gram-negative bacteria isolated from external eye infections. Infection 1974; 2: 162-5.
7. Gardner P, Griffin WB, Swartz MN, Kurtz LJ. Nonfermentative gramnegative bacilli of nosocomial interest. Am J Med 1970; 48: 735-49.
8. Seol SY, Jang KS, Jeong OG, Cho ER, Kim NH, Yu HS, et al. Antimicrobial resistance and molecular epidemiologic characteristics of Stenotrophomonas maltophilia isolated from clinical specimen. J Korean Soc Microbiol 2000; 35: 239-50.
9. Chang LL, Chen HF, Chang CY, Lee TM, Wu WJ. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 2004; 53: 518-21.
10. Zhang L, Li XZ, Poole K. SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45: 3497-503.
11. Sader HS and Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 2005; 25: 95-109.
12. Perreten V and Boerlin P. A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland. Antimicrob Agents Chemother 2003; 47: 1169-72.
13. Toleman MA, Bennett PM, Bennett DM, Jones RN, Walsh TR. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007; 13: 559-65.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement M100-S18 (M2). Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
15. Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J. Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods 2005; 62: 221-32.
16. Levesque C, Piche L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-91.
17. Lin CW, Chiou CS, Chang YC, Yang TC. Comparison of pulsed-field gel electrophoresis and three rep-PCR methods for evaluating the genetic relatedness of Stenotrophomonas maltophilia isolates. Lett Appl Microbiol 2008; 47: 393-8.
18. Garrison MW, Anderson DE, Campbell DM, Carroll KC, Malone CL, Anderson JD, et al. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother 1996; 40: 2859-64.
19. Fedler KA, Biedenbach DJ, Jones RN. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn Microbiol Infect Dis 2006; 56: 427-36.
20. Barbolla R, Catalano M Orman BE, Famiglietti A, Vay Q Smayevsky J, et al. Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother 2004; 48: 666-9.